Position in ASND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,315,395
+$4,887,680 QoQ
Shares Held
128,657
0.0% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#57
of 308 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ODDO BHF ASSET MANAGEMENT SAS holds $77,360,522 across 7 Biotechnology names. ASND ranks #1 (44.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
128,657 | $34,315,395 | |
| 2 | ARGX |
Argenx SE
|
25,009 | $23,202,599 | |
| 3 | ABVX |
Abivax S.A.
|
81,496 | $10,860,156 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,151 | $5,042,306 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,074 | $3,333,606 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
|
45,090 | $606,460 | |
| 7 | 227,386 | $0 |
All Filings in ASND
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,315,395 | 128,657 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $29,427,715 | 128,657 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $27,708,618 | 129,941 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,853,820 | 119,983 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,968,212 | 63,547 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||